SCHEMBL18901189

SCHEMBL18901189

CCCNCc1cccc(C(=O)NC2(C)CC2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 4/20 0.48
ROCK1 Q13464 1/20 0.48
SPHK2 Q9NRA0 1/20 0.46
SPHK1 Q9NYA1 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
ALDH1A1 P00352 2/20 0.41
ANO1 Q5XXA6 4/20 0.41
POLB P06746 1/20 0.41
MMP13 P45452 1/20 0.41
SMYD3 Q9H7B4 1/20 0.41
KDM1A O60341 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
NCOR2 Q9Y618 1/20 0.40
LMNA P02545 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18901186 0.85 ROCK2 (0.51) ROCK2ROCK1SPHK2SPHK1ALDH1A1
SCHEMBL17790246 0.84 ROCK2 (0.52) ROCK2ROCK1SPHK2SPHK1ALDH1A1
SCHEMBL19954235 0.81 ROCK2 (0.49) ROCK2ROCK1SPHK2SPHK1ANO1
SCHEMBL18901187 0.80 LOXL2 (0.55) ROCK2ROCK1SPHK2SPHK1ALDH1A1
SCHEMBL13753635 0.75 L3MBTL1 (0.58) L3MBTL1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL13753614 0.73 HDAC8 (0.59) SMN1; SMN2NPC1RAB9APOLBLMNA
SCHEMBL13753632 0.72 TP53 (0.61) L3MBTL1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL13753617 0.72 TP53 (0.56) L3MBTL1NPC1RAB9AALDH1A1ANO1
SCHEMBL20069766 0.72 PRMT5 (0.45) ROCK2ROCK1SPHK2SPHK1POLB
SCHEMBL18901384 0.71 ROCK2 (0.51) ROCK2ROCK1SMN1; SMN2RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3016951-B1 TRICYCLIC PYRIDO-CARBOXAMIDE DERIVATIVES AS ROCK INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-05-31 EP disclosed